Obesity is a strong determinant of hypertensive target organ damage in young-to-middle-age patients

International Journal of Obesity

Volumn 37, Issue 2, 2013, Pages 224-229

  Palatini, P ^a   Saladini, F ^a   Mos, L ^b   Benetti, E ^a   Bortolazzi, A ^b   Cozzio, S ^c   Casiglia, E ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Town Hospital   (Italy)

^c Town Hospital   (Italy)

Author keywords

ambulatory monitoring; left ventricular hypertrophy; microalbuminuria; overweight; target organ

Indexed keywords

ALBUMIN; HYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR SYSTEM; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OBESITY; ORGAN INJURY; PRIORITY JOURNAL; URINALYSIS;

ADULT; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BODY MASS INDEX; CREATININE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; OBESITY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK REDUCTION BEHAVIOR; WEIGHT LOSS;

EID: 84873730505     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.32     Document Type: Article

References (34)

1. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008; 52: 818-827.
2. Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 2011; 23: 1170-1178.
3. Timpson NJ, Harbord R, Davey Smith G, Timpson NJ, Harbord R, Davey Smith G. Does greater adiposity increase blood pressure and hypertension risk?: Mendelian randomization using the FTO/MC4R genotype. Hypertension 2009; 54: 84-90.
4. Narkiewicz K. Diagnosis and management of hypertension in obesity. Obes Rev 2006; 7: 155-162.
5. Viazzi F, Leoncini G, Adami GF, Papadia FS, Bezante GP, Conti N et al. Sub-clinical organ damage in hypertension and obesity. Nutr Metab Cardiovasc Dis 2011; 21: 597-602.
6. Kotsis VT, Stabouli SV, Papamichael CM, Zakopoulos NA. Impact of obesity in intima media thickness of carotid arteries. Obesity 2006; 14: 1708-1715.
7. Palatini P, Graniero G, Mormino P, Nicolosi L, Mos L, Visentin P et al. Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects. Results of the HARVEST trial. Circulation 1994; 90: 2870-2876.
8. Sartori M, Semplicini A, Siffert W, Mormino P, Mazzer A, Pegoraro F et al. G-protein beta3-subunit gene 825T allele and hypertension: a longitudinal study in young grade I hypertensives. Hypertension 2003; 42: 909-914.
9. Palatini P, Mormino P, Dorigatti F, Santonastaso M, Mos L, De Toni R et al. Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int 2006; 70: 578-584.
10. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 2004; 164: 2126-2134.
11. Sahn DJ, Demaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
12. Devereux RB, Lutas EM, Casale PN, Kilgfield P, Eisenberger RR, Hammond IW et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4: 1222-1230.
13. De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20: 1251-1260.
14. Palatini P, Visentin P, Dorigatti F, Guarnieri C, Santonastaso M, Cozzio S et al. Regular physical activity prevents development of left ventricular hypertrophy in hypertension. Eur Heart J 2009; 30: 225-232.
15. Winnicki M, Bonso E, Dorigatti F, Longo D, Zaetta V, Mattarei M et al. Effect of body weight loss on blood pressure after 6 years of follow-up in stage 1 hypertension. Am J Hypertens 2006; 19: 1103-1109.
16. Peduzzi P, Holford T, Detre K, Chan YK. Comparison of the logistic and Cox regression models when outcome is determined in all patients after a fixed period of time. J Chron Dis 1987; 40: 761-767.
17. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617-624.
18. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and ischemic heart disease. Hypertension 2000; 35: 898-903.
19. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580-586.
20. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001; 141: 334-341.
21. Daniels SR, Loggie JMH, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 1998; 97: 1907-1911.
22. Hanevold C, Waller J, Daniels S, Portman R, Sorof J. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 2004; 113: 328-333.
23. Torres Rosa T, Palatini P. Clinical value of microalbuminuria in hypertension. J Hypertens 2000; 18: 645-654.
24. Hoffmann IS, Jimenez E, Cubeddu LX. Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure. J Hum Hypertens 2001; 15: 407-412.
25. Schillaci G, Vaudo G, Reboldi G, Verdecchia P, Lupattelli G, Pasqualini L et al. Highdensity lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension. J Hypertens 2001; 19: 2265-2270.
26. Lee ZS, Critchley JA, Tomlinson B, Young RP, Thomas GN, Cockram CS et al. Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metabolism 2001; 50: 135-143.
27. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009; 54: 690-697.
28. Lambert E, Ika Sari C, Dawood T, Lee K, Chopra R, Straznicky N et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010; 56: 351-358.
29. Palatini P, Majahalme S, Amerena J, Nesbitt S, Vriz O, Michieletto M et al. Determinants of left ventricular structure and mass in young subjects with sympathetic over-activity: the Tecumseh Offspring Study. J Hypertens 2000; 18: 769-775.
30. Julius S, Valentini M, Palatini P. Overweight and hypertension: a 2-way street? Hypertension 2000; 35: 807-813.
31. Altman DG, Deeks JJ, Sackett DL. Odds ratios should be avoided when events are common. BMJ 1998; 317: 1318.
32. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004; 159: 882-890.
33. Bender R, Jockel KH, Trautner C, Spraul M, Berger M. Effect of age on excess mortality in obesity. JAMA 1999; 281: 1498-1504.
34. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998; 338: 1-7.